T Uptake
T Uptake
T Uptake
T-Uptake
T-uptake
11731394 122 200 tests Precautions and warnings
For in vitro diagnostic use.
• Indicates analyzers on which the kit can be used
Exercise the normal precautions required for handling all laboratory reagents.
MODULAR Disposal of all waste material should be in accordance with local guidelines.
Elecsys 1010 Elecsys 2010 ANALYTICS cobas e 411 cobas e 601 Safety data sheet available for professional user on request.
E170 Avoid the formation of foam with all reagents and sample types
• • • • • (specimens, calibrators, and controls).
Reagent handling
English The reagents in the kit have been assembled into a ready-for-use
unit that cannot be separated.
Intended use All information required for correct operation is read in via the
Immunoassay for the in vitro quantitative determination of thyroxine-binding respective reagent barcodes.
capacity (TBC or T4-uptake) in human serum and plasma.
The electrochemiluminescence immunoassay “ECLIA” is intended for Storage and stability
use on Elecsys and cobas e immunoassay analyzers. Store at 2-8 °C.
Store the Elecsys T-Uptake reagent kit upright in order to ensure complete
Summary1,2,3,4,5,6 availability of the microparticles during automatic mixing prior to use.
The thyroid hormone thyroxine (T4) is physiologically part of the regulating Stability:
circuit of the thyroid gland and has an effect on general metabolism.
The determination of the T4 concentration is of importance in laboratory unopened at 2-8 °C up to the stated expiration date
diagnostics for differentiating between euthyroid, hyperthyroid, and hypothyroid after opening at 2-8 °C 12 weeks
conditions. As the major fraction of the total thyroxine is bound to transport on MODULAR ANALYTICS E170 and
5 weeks
proteins (TBG, prealbumin, and albumin), the determination of total thyroxine cobas e 601
only provides correct information when the thyroxine-binding capacity in on Elecsys 2010 and cobas e 411 8 weeks
serum is normal. The free thyroid hormones are in equilibrium with the 8 weeks (stored alternately in the
hormones bound to the carrier proteins. A change in the TBG concentration refrigerator and on the analyzer -
can lead to elevated or lowered total T4 concentrations being measured on Elecsys 1010
ambient temperature 20-25 °C; up to
although the free T4 concentration is in the euthyroid range. 20 hours opened in total)
The performance of a T-uptake or TBC assay provides a measure
of the available thyroxine-binding sites. Specimen collection and preparation
Determination of the free thyroxine Index (fT4I) from the quotient of total T4 and Only the specimens listed below were tested and found acceptable.
TBI (thyroxine-binding index = result of the T-uptake determination) takes into Undiluted serum collected using standard sampling tubes or
account changes in the thyroid hormone carrier proteins and the thyroxine level. tubes containing separating gel.
The Elecsys T-Uptake assay is an immunological method for determining the Li-, Na-, NH+4-heparin, K3-EDTA, sodium citrate, and sodium
T-uptake (TBC), in which exogenous T4 is added to saturate the TBG. fluoride/potassium oxalate plasma (undiluted).
Test principle Criterion: Recovery within 90-110 % of serum value or slope 0.9-1.1 + intercept
Modified competition principle. Total duration of assay: 18 minutes. within < ± 2 x analytical sensitivity (LDL) + coefficient of correlation > 0.95.
Stable for 8 days at 2-8 °C, 3 months at -20 °C. Freeze only once.
• 1st incubation: 15 µL of sample, exogenous T4, and biotinylated
The sample types listed were tested with a selection of sample collection tubes
T4-polyhapten. The T4 occupies the free binding sites in the serum sample.
that were commercially available at the time of testing, i.e. not all available
• 2nd incubation: After addition of a T4-specific antibody labeled with
tubes of all manufacturers were tested. Sample collection systems from
a ruthenium complexa, the polyhapten and the antibody derivative
various manufacturers may contain differing materials which could affect
react to form a complex, the concentration of which is inversely
the test results in some cases. When processing samples in primary tubes
proportional to the concentration of the excess, exogenous T4. This
(sample collection systems), follow the instructions of the tube manufacturer.
immunological complex becomes bound to the added streptavidin-coated
Centrifuge samples containing precipitates before performing the
microparticles via interaction of biotin and streptavidin.
assay. Do not use heat-inactivated samples. Do not use samples
• The reaction mixture is aspirated into the measuring cell where the and controls stabilized with azide.
microparticles are magnetically captured onto the surface of the Ensure the patients’ samples, calibrators, and controls are at ambient
electrode. Unbound substances are then removed with ProCell. temperature (20-25 °C) before measurement.
Application of a voltage to the electrode then induces chemiluminescent Because of possible evaporation effects, samples, calibrators, and controls
emission which is measured by a photomultiplier. on the analyzers should be measured within 2 hours.
• Results are determined via a calibration curve which is
instrument-specifically generated by 2-point calibration. Materials provided
a) Tris(2,2’-bipyridyl)ruthenium(II)-complex (Ru(bpy)2+
3 )
See “Reagents - working solutions” section for reagents.
Reagents - working solutions Materials required (but not provided)
M Streptavidin-coated microparticles (transparent cap), 1 bottle, 12 mL: • Cat. No. 11731505122, T-Uptake CalSet, 4 x 1 mL
Streptavidin-coated microparticles 0.72 mg/mL; preservative. • Cat. No. 11731416122, PreciControl Universal, for 2 x 3 mL each of
R1 Poly-T4~biotin (gray cap), 1 bottle, 18 mL: PreciControl Universal 1 and 2 or
Biotinylated T4 polyhapten 70 ng/mL; thyroxine 60 ng/mL; Cat. No. 11731416190, PreciControl Universal, for 2 x 3 mL
phosphate buffer 100 mmol/L, pH 7.0; preservative. each of PreciControl Universal 1 and 2
R2 Anti-T4-Ab~Ru(bpy)2+3 (black cap), 1 bottle, 18 mL: • Cat. No. 11731416160, PreciControl Universal, for 2 x 3 mL each
Polyclonal anti-T4-antibody (sheep) labeled with ruthenium complex of PreciControl Universal 1 and 2 (for USA)
120 ng/mL; phosphate buffer 100 mmol/L, pH 7.0; preservative. • General laboratory equipment
• Elecsys 1010/2010, MODULAR ANALYTICS E170 or cobas e analyzer
Accessories for Elecsys 1010/2010 and cobas e 411 analyzers:
• Cat. No. 11662988122, ProCell, 6 x 380 mL system buffer
• Cat. No. 11662970122, CleanCell, 6 x 380 mL measuring
cell cleaning solution
T-Uptake
T-uptake
Each laboratory should investigate the transferability of the expected values to References
its own patient population and if necessary determine its own reference ranges. 1. Böttger HW, Pabst. Zur Interpretation und Wertigkeit der Schilddrüsen-in
vitro-Diagnostik. Der Nuklearmediziner 1980;3:217-227.
Specific performance data
2. Emrich D. Schilddrüsen-in vitro-Test. Therapiewoche 1989;30:6852-6859.
Representative performance data on the analyzers are given below.
3. Hampel R, Ventz M, Weber A, Meng W. Praktische Bedeutung von
Results obtained in individual laboratories may differ.
extrathyreoidalen Beeinflussungen der Schilddrüsenhormonparameter.
Precision Dt. Gesundh.-Wesen 1981;36:1977-1980.
Reproducibility was determined using Elecsys reagents, pooled human 4. Wheeler MH, Lazarus JH. Diseases of the Thyroid. London,
sera, and controls in a modified protocol (EP5-A) of the NCCLS (National Glasgow, Weinheim, New York, Tokyo, Melbourne, Madras:
Committee for Clinical Laboratory Standards): 6 times daily for 10 days Chapman and Hall Medical, 1994:108.
(n = 60); within-run precision on MODULAR ANALYTICS E170 analyzer, 5. Fisher DA. Physiological variations in thyroid hormones; physiological and
n = 21. The following results were obtained: pathophysiological considerations. Clin Chem 1996;42:135-139.
6. Pfannenstiel P, Saller B. Schilddrüsenkrankheiten Diagnose und Therapie.
Elecsys 1010/2010 and cobas e 411 analyzers Berliner Medizinische Verlagsanstalt GmbH 1995;2:55-56.
Within-run precision Total precision 7. Bantle JP, Hunninghake DB, Frantz ID, Kuba K, Mariash CN,
Sample Mean SD CV SD CV Oppenheimer JH. Comparison of Effectiveness of Thyrotropin-Suppressive
TBI TBI % TBI % Doses of D- and L-Thyroxine in Treatment of Hypercholesterolemia.
Human serum 1 1.80 0.012 0.7 0.016 0.9 Am J Med 1984;3:475-481.
Human serum 2 0.95 0.020 2.2 0.035 3.3 8. Wada N, Chiba H, Shimizu C, Kijima H, Kubo M, Koike T. A Novel Missense
Human serum 3 0.55 0.028 5.1 0.064 11.7 Mutation in Codon 218 of the Albumin Gene in a Distinct Phenotype
of Familial Dysalbuminemic Hyperthyroxinemia in a Japanese Kindred.
PreciControl Universal 1 1.09 0.026 2.4 0.029 2.7
Journal of Clinical Endocrinology and Metabolism 1997;82(10):3246-3250.
PreciControl Universal 2 0.94 0.031 3.3 0.034 3.7
9. Passing H, Bablok W, et al. A General Regression Procedure for Method
Transformation. J Clin Chem Clin Biochem 1988;26:783-790.
MODULAR ANALYTICS E170 and cobas e 601 analyzers
Within-run precision Total precision For further information, please refer to the appropriate operator’s manual
Sample Mean SD CV Mean SD CV for the analyzer concerned, the respective application sheets, the product
TBI TBI % TBI TBI % information, and the package inserts of all necessary components.
Human serum 1 0.71 0.01 2.0 0.68 0.03 4.9 FOR US CUSTOMERS ONLY: LIMITED WARRANTY
Human serum 2 0.87 0.02 2.6 0.92 0.04 3.9 Roche Diagnostics warrants that this product will meet the specifications
Human serum 3 1.40 0.01 0.8 1.41 0.02 1.5 stated in the labeling when used in accordance with such labeling and
PreciControl Universal 1 1.22 0.01 0.8 1.23 0.03 2.4 will be free from defects in material and workmanship until the expiration
PreciControl Universal 2 0.86 0.02 2.0 0.83 0.04 4.8 date printed on the label. THIS LIMITED WARRANTY IS IN LIEU OF ANY
OTHER WARRANTY, EXPRESS OR IMPLIED, INCLUDING ANY IMPLIED
Analytical sensitivity (lower detection limit) WARRANTY OF MERCHANTABILITY OR FITNESS FOR PARTICULAR
TBI: 0.200 PURPOSE. IN NO EVENT SHALL ROCHE DIAGNOSTICS BE LIABLE FOR
The detection limit represents the lowest measurable analyte level that INCIDENTAL, INDIRECT, SPECIAL OR CONSEQUENTIAL DAMAGES.
can be distinguished from zero. It is calculated as the value lying two
standard deviations above that of the lowest standard (master calibrator,
standard 1 + 2 SD, within-run precision, n = 21).
COBAS, COBAS E, ELECSYS, ENZYMUN-TEST and MODULAR are trademarks of Roche. INTRALIPID is a
Method comparison trademark of Fresenius Kabi AB. Other brand or product names are trademarks of their respective holders.
A comparison of the Elecsys T-Uptake assay (y) with the Enzymun-Test TBK Significant additions or changes are indicated by a change bar in the margin. Changes to reagent barcode
method (x) using clinical samples gave the following correlations: test parameters which have already been read in should be edited manually.
© 2009, Roche Diagnostics
Number of samples measured: 145
Passing/Bablok9 Linear regression
y = 1.03x - 0.15 y = 0.98x - 0.09 Roche Diagnostics GmbH, D-68298 Mannheim
τ = 0.717 r = 0.915 Distribution in USA by:
Roche Diagnostics, Indianapolis, IN
The sample TBI values were between 0.8 and 1.4. US Customer Technical Support 1-800-428-2336
Analytical specificity
For the antibody derivative used, the following cross-reactivities were found:
L-T4 and D-T4 100 %; L-T3 1.53 %; D-T3 1.38 %; 3-iodo-L-tyrosine 0.002 %;
3,5-diiodo-L-tyrosine 0.01 %; 3,3’,5,5’-tetraiodothyroacetic acid 38.5 %.